跳至主要内容
临床试验/ISRCTN11976737
ISRCTN11976737已完成未知

The effect of on demand versus continuous use of proton pump inhibitors on reflux symptoms, quality of life and self-rated health in patients with gastro-oesophageal reflux disease

Karolinska Institute0 个研究点目标入组 488 人开始时间: 2015年3月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
488

研究概览

简要总结

2019 results presented at the American Gastroenterological association (AGA) conference in https://www.gastrojournal.org/article/S0016-5085(19)37030-1/fulltext (added 06/10/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 18-65 years
  • 2. Predominant GORD cases with heartburn and/or acid regurgitation that need PPI treatment
  • 3. PPI responsive
  • 4. Ability to complete questionnaires

排除标准

  • 1. Known Barrett’s oesophagus
  • 2. Known severe oesophagitis (LA C or above)
  • 3. Continuous use of NSAID/aspirin
  • 4. Prophylactic PPI use to reduce the risk of ulcers in persons being treated with NSAIDs
  • 5. PPI treatment to heal an ulcer induced by NSAID treatment in the last 6 months
  • 6. PPI treatment for H. pylori eradication in the last 6 months
  • 7. Severe disorders other than GORD with a negative impact on quality of life
  • 8. Signs of upper gastrointestinal bleeding
  • 9. Alarm symptoms: unintentional weight loss/vomiting/difficulties swallowing
  • 10. Pregnancy

研究者

发起方
Karolinska Institute

相似试验